The Journal of Dermatology
© Japanese Dermatological Association
Edited By: Masutaka Furue
Impact Factor: 1.577
ISI Journal Citation Reports © Ranking: 2015: 30/61 (Dermatology)
Online ISSN: 1346-8138
1. SUMMARY OF SUBMISSION REQUIREMENTS
Thank you for your interest in The Journal of Dermatology. Please read the complete Author Guidelines carefully prior to submission, including the section on copyright and publication charges.
Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at http://mc.manuscriptcentral.com/jde For help with submissions, please contact: firstname.lastname@example.org
We look forward to your submission.
2. EDITORIAL CONSIDERATIONS
Aims and Scope
The Journal of Dermatology is the official peer-reviewed publication of the Japanese Dermatological Association and the Asian Dermatological Association. The journal aims to provide a forum for the exchange of information about new and significant research in dermatology and to promote the discipline of dermatology in Japan and throughout the world. Research articles are supplemented by reviews, theoretical articles, special features, commentaries, book reviews and proceedings of workshops and conferences. Preliminary or short reports and letters to the editor of two printed pages or less will be published as soon as possible. Papers in all fields of dermatology will be considered.
Editorial Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by two reviewers and the Editors. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. Final acceptance or rejection rests with the Editorial Board, who reserve the right to refuse any material for publication.
Instructions: only relevant if your Journal publishes human studies
For manuscripts reporting medical studies involving human participants, we require a statement identifying the ethics committee that approved the study, and that the study conforms to recognized standards, for example:
• Declaration of Helsinki
• US Federal Policy for the Protection of Human Subjects
• European Medicines Agency Guidelines for Good Clinical Practice
Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Patient anonymity should be preserved. Non-essential identifying details should be omitted.
Editors may request that reviewers comment on the standard of experimental reporting, experimental design, or any other aspects of the study reported that may cause concern. If concerns are raised or clarifications are needed, we may need to request evidence of ethical research approval.
Conflict of Interest
We require that all authors disclose any potential sources of conflict of interest. The existence of a conflict of interest does not preclude publication. A conflict of interest statement must be included within the manuscript (see section ‘Parts of the Manuscript’), and authors must also complete a Conflict of Interest form. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company.
To download Conflict of Interest form, please click here.
Completion the form is mandatory for all article categories. If the form is not included or complete, the manuscript will not be considered for peer review.
Authors should list all funding sources in the Acknowledgments section.
The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria: i) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; ii) Drafting the work or revising it critically for important intellectual content; iii) Final approval of the version to be published; and iv) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
Word limit: 6,000 words including abstract.
Figures/Tables: No limit
References: No limit.
Description: Arrange text as follows: (i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments, (v) conflict of interest, (vi) references, (vii) supporting information, (viii) figure legends, (ix) tables (each table complete with title and footnotes) and (x) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Word limit: 1,500 words including abstract
Figures/Tables: Up to 3
References: Up to 15.
Description: a) A case report with mini review or with new observations of diseases, clinical findings or novel treatment outcomes; OR b) a brief research paper. Arrange text as follows: (i) title page, (ii)abstract and key words, (iii) text, (iv)acknowledgments, (v) conflict of interest, (vi) references, (vii) supporting information, (viii) figure legends, (ix) tables (each table complete with title and footnotes) and (x) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Word limit: 750 words
Authors: Maximum 5 authors.
Abstract: No abstract.
References: Up to 7.
Figures/ tables: Up to 1 (Additional tables/figures should be submitted as Supporting Information) Description: Research Notes are brief summary of interesting findings in basic research, reporting preliminary data relevant to the field. It should not include a detailed report or discussion but a concise and short description of the data and the findings.
Word limit: 5,000 words.
References: No limit.
Figures/tables: No limit. (Minimum 1 image or figure)
Description: Reviews are comprehensive analyses of specific topics. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.
Letters to the Editor
Word limit: 500 words
Authors: Maximum ten authors.
Abstract: No abstract.
References: Up to 5.
Figures/ tables: Up to 1 (Multi panel figures allowed).
Description: The journal publishes two types of Letters to the Editor, listed below. Letters to the Editor of one printed pages or less will be published as soon as possible.
(i) Notes & Comments: Letters may be submitted to the Editor on any topic of discussion; clinical observations as well as letters commenting on papers published in recent issues.
(ii) Case Letters: Conclusions based on uncontrolled trials and/or limited experience should be stated in appropriately tentative terms. Concise descriptions detailing one or two patients, early reports of therapeutic trials in one or several patients, and early reports of new drug reactions.
4. PREPARING THE MANUSCRIPT
English Language and Editing Help
Wiley’s English Language and Editing Service guarantees that your paper is not rejected for English language and formatting reasons. Covering English language editing support, translation services, manuscript formatting and figure preparation help, Wiley’s service ensures that your manuscript is ready for submission.
Writing for Search Engine Optimization
Optimize the search engine results for your paper, so people can find, read and ultimately cite your work. Simply read our best practice SEO tips – including information on making your title and abstract SEO-friendly, and choosing appropriate keywords.
Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at http://www.ICMJE.org.
Spelling: The journal uses US spelling and authors should therefore follow the latest edition of the Merriam-Webster’s Collegiate Dictionary.
Units: All measurements must be given in SI or SI-derived units. Please go to the Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units.
Abbreviations:Abbreviations should be used sparingly -only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Trade names: Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.
Parts of the Manuscript
The length of manuscripts must adhere to the specifications under the section Manuscript Categories.
Manuscripts should be presented in the following order: (i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments, (v) conflict of interest statement, (vi) references, (viii) figure legends, and (ix) tables (each table complete with title and footnotes). Figures and supporting information should be supplied in separate files.
The title page should contain:
(i) a short informative title that contains the major key words. The title should not contain abbreviations (see Wiley’s best practice SEO tips)
(ii) the names and institutional affiliations of all authors;
(iii) a short running title (no more than 40 characters, abbreviations are permitted)
The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
Abstract and key words
All articles must have a brief abstract that states in 250 words the purpose, basic procedures, main findings and principal conclusions of the study. The abstract should not contain abbreviations or references.
Five key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine’s Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html.
Authors should use the following subheadings to divide the sections of their manuscript: Introduction, Methods, Results and Discussion.
The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.
Conflict of Interest Statement (applies to all article types)
In this section authors must describe any interest or relationship, financial or otherwise, that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The absence of any interest to disclose must also be stated.
References follow the Vancouver style, i.e. numbered sequentially as they occur in the text and ordered numerically in the reference list.
• All citations mentioned in the text, tables or figures must be listed in the reference list.
• If cited in tables or figure legends, number according to the first identification of the table or figure in the text.
• Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data).
• Authors are responsible for the accuracy of the references.
• Cite the names of all authors when there are six or fewer; when seven or more, list the first three followed by et al.
<Cite the names of all authors when there are six or fewer>
Inoue N, Dainichi T, Fujisawa A, Nakano H, Sawamura D, Kabashima K. CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis. J Dermatol 2016; 43: 187–189.
<Cite article has more than seven authors, list the first three followed by et al.>
Chapman PB, Hauschild A, Robert C et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507–2516
Online Article Not Yet Published in an Issue
An online article that has not yet been published in an issue (therefore has no volume, issue or page numbers) can be cited by its Digital Object Identifier (DOI). The DOI will remain valid and allow an article to be tracked even after its allocation to an issue.
Williams K, Galerneau F. Maternal transcranial Doppler in pre-eclampsia and eclampsia. Ultrasound Obstet Gynecol 2003. DOI: 10.1002/uog.83.
Kaufmann HE, Baron BA, McDonald MB, Wlatman SR (eds). The Cornea, 2nd edn. New York: Churchill Livingstone, 1998.
Chapter in a Book
McEwen WK, Goodner IK. Secretion of tears and blinking. In: Davidson H (ed). The Eye, Vol 3, 2nd edn. New York: Academic Press, 1969; 34–78.
Cancer-Pain.org [homepage on the internet]. New York: Association of Cancer Online Resources, Inc.; c2000–01 [Cited 2015 May 11]. Available from: http://www.cancer-pain.org/.
Tables should be self-contained and complement, but not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement. Figure legends should be included within the main text document.
Although we encourage authors to send us the highest-quality figures possible, for peer-review purposes we are happy to accept a wide variety of formats, sizes, and resolutions.
Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.
Color figures: Figures submitted in color may be reproduced in color online and in print free of charge, if they are of sufficient quality. Please note, however, that it is preferable that line figures (eg graphs and charts) and supplied in black and white so that they are legible if printed by a reader in black and white.
Supporting information is hosted online separately to the article. This should be used for information that is not essential to the article but that provides greater depth and background. It may include tables, figures, videos, datasets, etc. This material can be submitted with your manuscript, and will appear online, without editing or typesetting. Guidelines on how to prepare this material and which formats and files sizes are acceptable can be found at: http://exchanges.wiley.com/authors/supporting-information-guide_336.html
Please note that the provision of supporting information is not encouraged as a general rule. It will be assessed critically by reviewers and editors and will only be accepted if it is essential.
5. SUBMISSION OF MANUSCRIPTS
Manuscripts should be submitted online at http://mc.manuscriptcentral.com/jde.
• Cover letter should be included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file not for review. The cover letter should include an authorship declaration. Submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. This must be stated in the covering letter. Also contain an acknowledgment that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be quantified. If tables or figures have been reproduced from another source, a letter from the copyright holder, stating authorization to reproduce the material, must be attached to the covering letter.
• Each figure should be supplied as a separate file, with the figure number incorporated in the fi le name. Multi-panel figures (figures with parts a, b, c, d, etc.) should be submitted as a single file that contains all parts of the figure. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files should be uploaded. Digital images supplied as low-resolution PowerPoint files or PDFs cannot be used.
• Author material archive policy, authors who require the return of any submitted material that is accepted for publication should inform the Editorial Office after acceptance. If no indication is given that author material should be returned, Wiley will dispose of all hardcopy and electronic material two months after publication.
6. COPYRIGHT, LICENSING AND ONLINE OPEN
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.
Authors may choose to publish under the terms of the journal’s standard copyright transfer agreement (CTA), or under open access terms made available via Wiley OnlineOpen.
Standard Copyright Transfer Agreement: FAQs about the terms and conditions of the standard CTA in place for the journal, including standard terms regarding archiving of the accepted version of the paper, are available at: Copyright Terms and Conditions FAQs.
Note that in signing the journal’s licence agreement authors agree that consent to reproduce figures from another source has been obtained.
OnlineOpen – Wiley’s Open Access Option: OnlineOpen is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons license. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access. Authors of OnlineOpen articles are permitted to post the final, published PDF of their article on their personal website, and in an institutional repository or other free public server immediately after publication. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY NC ND). To preview the terms and conditions of these open access agreements please visit the Copyright Terms and Conditions FAQs.
Funder Open Access and Self-Archiving Compliance: Please click here for more information on Wiley’s compliance with specific Funder Open Access and Self Archiving Policies, and click here for more detailed information specifically about Self-Archiving definitions and policies.
7. PUBLICATION PROCESS AFTER ACCEPTANCE
Wiley Author Services: Tracking your article’s progress
Author Services enables authors to track their article throughout the production process to publication. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The corresponding author will receive a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://exchanges.wiley.com/authors/publication_283.html for more details on online production tracking.
The corresponding author will receive an e-mail alert containing a link to their PDF article proof as well as details on how to provide proof corrections. It is therefore essential that a working e-mail address be provided for the corresponding author. Note that proofs should be returned 48 hours from receipt of first proof. Please note that the author is responsible for all statements made in their work, including changes made during the editorial process and thus you must check your proofs carefully.
There is a publication charge of ¥20,000/US$200 per printed page. A form requesting payment will be available for download with your PDF proof.
The journal offers rapid speed to publication via Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in an issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before allocation to an issue. After issue publication, the DOI remains valid and can continue to be used to cite and access the article.
8. POST PUBLICATION
Article PDF for authors
A PDF of the published article will be made available to the authors free of charge via Author Services.
Printed offprints may be ordered online for a fee. Please click on the following link and fill in the necessary details and ensure that you type information in all of the required fields: http://offprint.cosprinters.com/cos. If you have queries about offprints please e-mail: email@example.com
Promoting Your Work
Wiley’s worldwide network and deep collection of content allows us to promote articles published on Wiley Online Library far and wide. We also invest heavily in search engine optimization and usability to ensure the widest possible visibility of the articles we publish. We make it easy for readers to find, read and cite your work.
You can also help increase the impact of your work by promoting your article yourself. The Wiley Author Promotional Toolkit provides you with information on how to use social media, publicity, conferences, multimedia, email and the web to promote your article.
Japanese Dermatological Association
The Journal of Dermatology
Professor Masutaka Furue
1-4 Hongo-4-chome, Bunkyo-ku Tokyo
Tel: +81 3 3811 5099; Fax: +81 3 3812 6790
Author Guidelines updated March 2016